Terms: = Germ cell tumor AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Treatment
182 results:
1. Ectopic pheochromocytomas in the third trimester: A case report and literature review.
Zhao L; Chen M; Chen X; Yu L; Du SG; Gan Q; Yang WZ; Jiang C; Xiao M
Medicine (Baltimore); 2024 Feb; 103(5):e36127. PubMed ID: 38306535
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paraganglioma.
Park YG; Park I; Kim Y; Lee HS; Lee W; Yoon S; Lee JL
Clin Genitourin Cancer; 2024 Apr; 22(2):413-419. PubMed ID: 38228412
[TBL] [Abstract] [Full Text] [Related]
3. Animal and cell Culture Models of Ppgls - Achievements and Limitations.
Karna B; Pellegata NS; Mohr H
Horm Metab Res; 2024 Jan; 56(1):51-64. PubMed ID: 38171372
[TBL] [Abstract] [Full Text] [Related]
4. Pheochromocytoma and paraganglioma in children and adolescents.
Stachowicz-Stencel T; Pasikowska N; Synakiewicz A
Acta Biochim Pol; 2023 Sep; 70(3):487-493. PubMed ID: 37717273
[TBL] [Abstract] [Full Text] [Related]
5. CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (
Grand-Guillaume J; Mansi R; Gaonkar RH; Zanger S; Fani M; Eugster PJ; Beck Popovic M; Grouzmann E; Abid K
J Transl Med; 2023 Sep; 21(1):604. PubMed ID: 37679770
[TBL] [Abstract] [Full Text] [Related]
6. Visual analytics identifies key miRNAs for differentiating peripancreatic paraganglioma and pancreatic neuroendocrine tumors.
Enguita JM; Díaz I; García D; Cubiella T; Chiara MD; Valdés N
Front Endocrinol (Lausanne); 2023; 14():1162725. PubMed ID: 37383401
[TBL] [Abstract] [Full Text] [Related]
7. Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review.
Wang X; Zhao Y; Liao Z; Zhang Y
Front Endocrinol (Lausanne); 2023; 14():1129622. PubMed ID: 37152961
[TBL] [Abstract] [Full Text] [Related]
8. Surgical and postsurgical management of abdominal paragangliomas and pheochromocytomas.
Araujo-Castro M; Pascual-Corrales E; Lorca Álvaro J; Mínguez Ojeda C; Pian H; Ruz-Caracuel I; Sanjuanbenito Dehesa A; Serrano Romero AB; Alonso-Gordoa T; Molina-Cerrillo J; Gómez Dos Santos V
Actas Urol Esp (Engl Ed); 2023 Mar; 47(2):68-77. PubMed ID: 37078847
[TBL] [Abstract] [Full Text] [Related]
9. Tumour microenvironment in pheochromocytoma and paraganglioma.
Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E
Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265
[TBL] [Abstract] [Full Text] [Related]
10. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline sdhd pathogenic variants.
Taïeb D; Wanna GB; Ahmad M; Lussey-Lepoutre C; Perrier ND; Nölting S; Amar L; Timmers HJLM; Schwam ZG; Estrera AL; Lim M; Pollom EL; Vitzthum L; Bourdeau I; Casey RT; Castinetti F; Clifton-Bligh R; Corssmit EPM; de Krijger RR; Del Rivero J; Eisenhofer G; Ghayee HK; Gimenez-Roqueplo AP; Grossman A; Imperiale A; Jansen JC; Jha A; Kerstens MN; Kunst HPM; Liu JK; Maher ER; Marchioni D; Mercado-Asis LB; Mete O; Naruse M; Nilubol N; Pandit-Taskar N; Sebag F; Tanabe A; Widimsky J; Meuter L; Lenders JWM; Pacak K
Lancet Diabetes Endocrinol; 2023 May; 11(5):345-361. PubMed ID: 37011647
[TBL] [Abstract] [Full Text] [Related]
11. Metabolic Characterization and Glyceraldehyde-3-Phosphate Dehydrogenase-Dependent Regulation of Epithelial Sodium Channels in hPheo1 Wild-type and SDHB Knockdown cells.
Bala N; Yu L; Liu LP; Shelton L; Xu Y; Ghayee HK; Alli AA
Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36763043
[TBL] [Abstract] [Full Text] [Related]
12. High rates of the SDHB p.Arg46Gln pathogenic variant predisposes New Zealand Māori to phaeochromocytoma/paraganglioma.
Shand JAD; van Schalkwyk J; Beavis V; Niyagama A; Taylor S; Eagleton C
Intern Med J; 2023 Oct; 53(10):1883-1889. PubMed ID: 36346292
[TBL] [Abstract] [Full Text] [Related]
13. Response to targeted radionuclide therapy with [
Prado-Wohlwend S; Del Olmo-García MI; Bello-Arques P; Merino-Torres JF
Front Endocrinol (Lausanne); 2022; 13():957172. PubMed ID: 36339441
[TBL] [Abstract] [Full Text] [Related]
14. A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an sdhd pathogenic variant.
Foley M; Sharma A; Garfield K; Maese L; Buchmann L; Boyle J; Kohlmann W; Jeter J; Greenberg S
Fam Cancer; 2023 Apr; 22(2):217-224. PubMed ID: 36223042
[TBL] [Abstract] [Full Text] [Related]
15. A rare case report of multifocal para-aortic and para-vesical paragangliomas.
Xiong SC; Di XP; Zhang MN; Wu K; Li X
Front Endocrinol (Lausanne); 2022; 13():946496. PubMed ID: 36004346
[TBL] [Abstract] [Full Text] [Related]
16. Integration of synthetic and natural derivatives revives the therapeutic potential of temozolomide against glioma- an in vitro and in vivo perspective.
Daisy Precilla S; Kuduvalli SS; Angeline Praveena E; Thangavel S; Anitha TS
Life Sci; 2022 Jul; 301():120609. PubMed ID: 35526592
[TBL] [Abstract] [Full Text] [Related]
17. Model systems in SDHx-related pheochromocytoma/paraganglioma.
Takács-Vellai K; Farkas Z; Ősz F; Stewart GW
Cancer Metastasis Rev; 2021 Dec; 40(4):1177-1201. PubMed ID: 34957538
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy and safety of
Yadav MP; Ballal S; Sahoo RK; Bal C
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1595-1606. PubMed ID: 34837103
[TBL] [Abstract] [Full Text] [Related]
19. [Endocrine and neuroendocrine tumors].
Riss P; Scheuba K; Strobel O
Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
[TBL] [Abstract] [Full Text] [Related]
20. A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective.
Lee Y; Tan LYR; Shakoor SAKKA
Singapore Med J; 2022 Nov; 63(11):649-658. PubMed ID: 34602493
[TBL] [Abstract] [Full Text] [Related]
[Next]
